Oncotartis raised $1.85 million in a Series B financing from its original investor – Bioprocess Capital Ventures. Proceeds will be used to complete all IND-enabling works and prepare for IND submission.
Oncotartis raised $1.85 million in a Series B financing from its original investor – Bioprocess Capital Ventures. Proceeds will be used to complete all IND-enabling works and prepare for IND submission.